NCT02949934View on ClinicalTrials.gov

Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

April 13, 2021

Study Completion Date

April 13, 2021

Conditions
Alcohol Use Disorder
Interventions
DRUG

Tolcapone

DRUG

Placebo

Trial Locations (1)

29403

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Medical University of South Carolina

OTHER

NCT02949934 - Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control | Biotech Hunter | Biotech Hunter